Clinical Trials Directory

Trials / Completed

CompletedNCT06734143

High Diagnostic Performance of the Indicator Plaster Neuropad for the Detection of Diabetic Autonomic Neuropathy

Diagnostic Performance of the Indicator Plaster Neuropad for the Detection of Diabetic Autonomic Neuropathy: a Validation Study

Status
Completed
Phase
Study type
Observational
Enrollment
174 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

Diabetic autonomic neuropathy (DAN) is a prevalent and severe complication of Diabetes Mellitus (DM). When the autonomic regulation of the cardiovascular system is affected, it is referred to as cardiovascular autonomic neuropathy (CAN), the most critical subtype of DAN. Early diagnosis of CAN is crucial, as it can identify patients at elevated risk for cardiovascular complications. This study aimed to assess the Neuropad test's effectiveness, specificity, sensitivity, and accuracy as a diagnostic tool for detecting DAN.

Detailed description

Diabetic autonomic neuropathy (DAN) is a prevalent and severe complication of Diabetes Mellitus (DM). When the autonomic regulation of the cardiovascular system is affected, it is referred to as cardiovascular autonomic neuropathy (CAN), the most critical subtype of DAN. Early diagnosis of CAN is crucial, as it can identify patients at elevated risk for cardiovascular complications. This study aimed to assess the Neuropad test's effectiveness, specificity, sensitivity, and accuracy as a diagnostic tool for detecting DAN.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNeuropadNeuropad examination was performed in all patients, after 10 minutes of rest without socks in a well-temperatured room. The result was considered normal if there was a complete color change and abnormal if there was no or incomplete color change.

Timeline

Start date
2022-06-01
Primary completion
2023-06-30
Completion
2023-07-31
First posted
2024-12-16
Last updated
2025-02-20

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT06734143. Inclusion in this directory is not an endorsement.